Amanda N Ruggieri (Amanda Ruggieri)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Inflammatory Response

Peripheral Blood

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Cancer immunology research

Emory University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Emory University

United States

PHD

Quinnipiac University

United States

MSC

Quinnipiac University

United States

BSC

Publications

Amanda N Ruggieri, Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X Chen, Brian M Olson, Chrystal M Paulos, Bassel F El-Rayes, Shishir K Maithel, Nilofer S Azad, Gregory B Lesinski
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Lauren Dennison, Amanda N Ruggieri, Aditya Mohan, James Leatherman, Kayla Cruz, Skylar Woolman, Nilofer Azad, Gregory B Lesinski, Elizabeth D Thompson, Mark Yarchoan
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy. Cancer immunology research 9 (10) (2021)
Yuchen Zhang, Michael B Ware, Mohammad Y Zaidi, Amanda N Ruggieri, Brian M Olson, Hannah Komar, Matthew R Farren, Ganji Purnachandra Nagaraju, Zhengjia Chen, Juan M Sarmiento, Rafi Ahmed, Shishir K Maithel, Bassel F El-Rayes, Gregory B Lesinski
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer. Molecular cancer therapeutics 20 (1) (2020)